Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4/A Open-market buy 10% owner bought 45,000 shares at $3.60 ($162,000)
  5. 4/A Open-market buy 10% owner bought 45,000 shares at $3.65 ($164,250)
  6. 4 Open-market buy 10% owner bought 45,000 shares at $3.65 ($164,250)
  7. 4 Exercise or conversion Chief Financial Officer acquired 15,000 shares (option exercise)
  8. 4 Grant or award Director acquired 4,573 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Director acquired 4,469 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy 10% owner bought 35,000 shares at $7.90 ($276,500)
  13. 4 Open-market sale 10% owner sold 410,000 shares at an average $8.00 ($3,280,198)
  14. 4 Open-market buy 10% owner bought 2,801 shares at $8.00 ($22,408)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 6,281 shares (grant or award)
  18. 4 Grant or award Director acquired 6,281 shares (grant or award)
  19. 4 Grant or award Director acquired 6,281 shares (grant or award)
  20. 4 Grant or award Director acquired 6,281 shares (grant or award)

Page 11 of 15 · 296 filings